232 related articles for article (PubMed ID: 30180161)
1. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
2. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort.
Hüsing A; Fortner RT; Kühn T; Overvad K; Tjønneland A; Olsen A; Boutron-Ruault MC; Severi G; Fournier A; Boeing H; Trichopoulou A; Benetou V; Orfanos P; Masala G; Pala V; Tumino R; Fasanelli F; Panico S; Bueno de Mesquita HB; Peeters PH; van Gills CH; Quirós JR; Agudo A; Sánchez MJ; Chirlaque MD; Barricarte A; Amiano P; Khaw KT; Travis RC; Dossus L; Li K; Ferrari P; Merritt MA; Tzoulaki I; Riboli E; Kaaks R
Clin Cancer Res; 2017 Aug; 23(15):4181-4189. PubMed ID: 28246273
[No Abstract] [Full Text] [Related]
3. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
Tikk K; Sookthai D; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Rosso S; Panico S; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Huerta Castaño JM; Ardanaz E; Bueno-de-Mesquita HB; Monninkhof E; Onland-Moret C; Andersson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Dossus L; Kaaks R
Ann Oncol; 2014 Jul; 25(7):1422-1428. PubMed ID: 24718887
[TBL] [Abstract][Full Text] [Related]
4. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
Collister JA; Liu X; Littlejohns TJ; Cuzick J; Clifton L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):812-820. PubMed ID: 38630597
[TBL] [Abstract][Full Text] [Related]
6. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
7. Association between cutaneous nevi and breast cancer in the Nurses' Health Study: a prospective cohort study.
Zhang M; Zhang X; Qureshi AA; Eliassen AH; Hankinson SE; Han J
PLoS Med; 2014 Jun; 11(6):e1001659. PubMed ID: 24915186
[TBL] [Abstract][Full Text] [Related]
8. Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.
Burton A; Maskarinec G; Perez-Gomez B; Vachon C; Miao H; Lajous M; López-Ridaura R; Rice M; Pereira A; Garmendia ML; Tamimi RM; Bertrand K; Kwong A; Ursin G; Lee E; Qureshi SA; Ma H; Vinnicombe S; Moss S; Allen S; Ndumia R; Vinayak S; Teo SH; Mariapun S; Fadzli F; Peplonska B; Bukowska A; Nagata C; Stone J; Hopper J; Giles G; Ozmen V; Aribal ME; Schüz J; Van Gils CH; Wanders JOP; Sirous R; Sirous M; Hipwell J; Kim J; Lee JW; Dickens C; Hartman M; Chia KS; Scott C; Chiarelli AM; Linton L; Pollan M; Flugelman AA; Salem D; Kamal R; Boyd N; Dos-Santos-Silva I; McCormack V
PLoS Med; 2017 Jun; 14(6):e1002335. PubMed ID: 28666001
[TBL] [Abstract][Full Text] [Related]
9. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR
Breast Cancer Res; 2024 Jan; 26(1):2. PubMed ID: 38167144
[TBL] [Abstract][Full Text] [Related]
10. Application of the Rosner-Colditz risk prediction model to estimate sexual orientation group disparities in breast cancer risk in a U.S. cohort of premenopausal women.
Austin SB; Pazaris MJ; Rosner B; Bowen D; Rich-Edwards J; Spiegelman D
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2201-8. PubMed ID: 23035180
[TBL] [Abstract][Full Text] [Related]
11. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
[TBL] [Abstract][Full Text] [Related]
12. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.
Li K; Anderson G; Viallon V; Arveux P; Kvaskoff M; Fournier A; Krogh V; Tumino R; Sánchez MJ; Ardanaz E; Chirlaque MD; Agudo A; Muller DC; Smith T; Tzoulaki I; Key TJ; Bueno-de-Mesquita B; Trichopoulou A; Bamia C; Orfanos P; Kaaks R; Hüsing A; Fortner RT; Zeleniuch-Jacquotte A; Sund M; Dahm CC; Overvad K; Aune D; Weiderpass E; Romieu I; Riboli E; Gunter MJ; Dossus L; Prentice R; Ferrari P
Breast Cancer Res; 2018 Dec; 20(1):147. PubMed ID: 30509329
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.
Tian Y; Lin Y; Qu C; Arndt V; Baurley JW; Berndt SI; Bien SA; Bishop DT; Brenner H; Buchanan DD; Budiarto A; Campbell PT; Carreras-Torres R; Casey G; Chan AT; Chen R; Chen X; Conti DV; Díez-Obrero V; Dimou N; Drew DA; Figueiredo JC; Gallinger S; Giles GG; Gruber SB; Gunter MJ; Harlid S; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jenkins MA; Jordahl KM; Joshi AD; Keku TO; Kawaguchi E; Kim AE; Kundaje A; Larsson SC; Marchand LL; Lewinger JP; Li L; Moreno V; Morrison J; Murphy N; Nan H; Nassir R; Newcomb PA; Obón-Santacana M; Ogino S; Ose J; Pardamean B; Pellatt AJ; Peoples AR; Platz EA; Potter JD; Prentice RL; Rennert G; Ruiz-Narvaez EA; Sakoda LC; Schoen RE; Shcherbina A; Stern MC; Su YR; Thibodeau SN; Thomas DC; Tsilidis KK; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; White E; Wolk A; Woods MO; Wu AH; Peters U; Gauderman WJ; Hsu L; Chang-Claude J
Br J Cancer; 2024 Jun; 130(10):1687-1696. PubMed ID: 38561434
[TBL] [Abstract][Full Text] [Related]
14. Bioavailable serum estradiol may alter radiation risk of postmenopausal breast cancer: a nested case-control study.
Grant EJ; Cologne JB; Sharp GB; Eguchi H; Stevens RG; Izumi S; Kim YM; Berrington de González A; Ohishi W; Nakachi K
Int J Radiat Biol; 2018 Feb; 94(2):97-105. PubMed ID: 29307255
[TBL] [Abstract][Full Text] [Related]
15. Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.
Pastor-Barriuso R; Ascunce N; Ederra M; Erdozáin N; Murillo A; Alés-Martínez JE; Pollán M
Breast Cancer Res Treat; 2013 Feb; 138(1):249-59. PubMed ID: 23378108
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Maas P; Barrdahl M; Joshi AD; Auer PL; Gaudet MM; Milne RL; Schumacher FR; Anderson WF; Check D; Chattopadhyay S; Baglietto L; Berg CD; Chanock SJ; Cox DG; Figueroa JD; Gail MH; Graubard BI; Haiman CA; Hankinson SE; Hoover RN; Isaacs C; Kolonel LN; Le Marchand L; Lee IM; Lindström S; Overvad K; Romieu I; Sanchez MJ; Southey MC; Stram DO; Tumino R; VanderWeele TJ; Willett WC; Zhang S; Buring JE; Canzian F; Gapstur SM; Henderson BE; Hunter DJ; Giles GG; Prentice RL; Ziegler RG; Kraft P; Garcia-Closas M; Chatterjee N
JAMA Oncol; 2016 Oct; 2(10):1295-1302. PubMed ID: 27228256
[TBL] [Abstract][Full Text] [Related]
17. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
Wang X; Huang Y; Li L; Dai H; Song F; Chen K
Breast Cancer Res; 2018 Mar; 20(1):18. PubMed ID: 29534738
[TBL] [Abstract][Full Text] [Related]
18. Polygenic risk score-based prediction of breast cancer risk in Taiwanese women with dense breast using a retrospective cohort study.
Hung CC; Moi SH; Huang HI; Hsiao TH; Huang CC
Sci Rep; 2024 Mar; 14(1):6324. PubMed ID: 38491043
[TBL] [Abstract][Full Text] [Related]
19. Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II.
Hirko KA; Fortner RT; Hankinson SE; Wu T; Eliassen AH
Breast Cancer Res Treat; 2016 Jul; 158(1):149-155. PubMed ID: 27294610
[TBL] [Abstract][Full Text] [Related]
20. Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors.
Yang H; Holowko N; Grassmann F; Eriksson M; Hall P; Czene K
BMC Med; 2020 Aug; 18(1):225. PubMed ID: 32838791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
